Technical Analysis for BME - Blackrock Health Sciences Trust

Grade Last Price % Change Price Change
grade B 40.2 0.50% 0.20
BME closed up 0.5 percent on Friday, November 15, 2019, on 85 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical BME trend table...

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Overbought Stochastic Strength 0.00%
Cup with Handle Other 0.50%
NR7 Range Contraction 0.50%
Overbought Stochastic Strength 0.50%
Pocket Pivot Bullish Swing Setup 0.47%
Stochastic Reached Overbought Strength 0.47%
Multiple of Ten Bullish Other 0.47%
Overbought Stochastic Strength 0.47%

Older signals for BME ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
BME Chart by TradingView
Basic chart:
Profile
BlackRock Health Sciences Trust is a close ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets across the globe. The fund invests in the stocks of companies operating in the healthcare sector which includes businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment or services or that provide support services to these companies. It benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.
Is BME a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Nov 6 Senate hearing on FDA nominee November 20
Nov 1 Price tag for Warren's universal healthcare: $20.5T
Oct 29 Drug shortages reflect "broken market" - FDA
Oct 20 Senator Warren to release funding plan for universal healthcare "soon"
Oct 17 Pelosi drug bill passes first House committee
Oct 15 Pelosi drug bill would save $345B - CBO
Oct 8 AbbVie and Roche price hike leaders past two years
Oct 3 BME: A Defensive Health Care CEF, But Price Is A Bit Steep
Sep 8 BlackRock CEFs to buy back up to 5% of shares
Sep 5 Certain BlackRock Closed-End Funds Announce Renewal of Share Repurchase Programs
See more BME news...
Indicators
Indicator Value
52 Week High 42.49
52 Week Low 32.0
Average Volume 27,828
200-Day Moving Average 38.6143
50-Day Moving Average 38.3864
20-Day Moving Average 39.2625
10-Day Moving Average 39.664
Average True Range 0.5851
ADX 30.92
+DI 24.1863
-DI 10.0703
Chandelier Exit (Long, 3 ATRs ) 38.6347
Chandelier Exit (Short, 3 ATRs ) 39.2311
Upper Bollinger Band 40.4217
Lower Bollinger Band 38.1033
Percent B (%b) 0.9
BandWidth 5.904871
MACD Line 0.5183
MACD Signal Line 0.4497
MACD Histogram 0.0685
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 40.71
Resistance 3 (R3) 40.72 40.55 40.63
Resistance 2 (R2) 40.55 40.42 40.55 40.60
Resistance 1 (R1) 40.38 40.34 40.30 40.37 40.57
Pivot Point 40.21 40.21 40.17 40.21 40.21
Support 1 (S1) 40.04 40.08 39.96 40.03 39.83
Support 2 (S2) 39.87 40.00 39.87 39.80
Support 3 (S3) 39.70 39.87 39.78
Support 4 (S4) 39.69